Delivery Order SPE2DB22D1106-SPE2DB25FERC3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. The award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract ceiling value of $2,812.92 and a firm fixed-price structure. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,694.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $7,934.79 delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 250 mg tablets (60-count units) on May 16, 2025, with an ultimate completion date of May 19, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen Drug Corp's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,312.52 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60 count) on December 2, 2025, with a completion date of December 3, 2025. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.28 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERC3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,617.25 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Nucynta ER, a controlled-release pain management pharmaceutical, reflects the contractor's ongoing role in fulfilling pharmaceutical supply requirements for Defense Health Agency customers and other federal healthcare systems through its comprehensive prime vendor agreement with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/2/25 |